Magnetar Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Buy |
+6,556
| New | +$319K | ﹤0.01% | 682 |
|
|
2025
Q1 | – | Sell |
-9,125
| Closed | -$359K | – | 768 |
|
|
2024
Q4 | $359K | Buy |
+9,125
| New | +$359K | 0.01% | 433 |
|
|
2023
Q4 | – | Sell |
-14,533
| Closed | -$660K | – | 402 |
|
|
2023
Q3 | $660K | Buy |
14,533
+6,971
| +92% | +$316K | 0.02% | 291 |
|
|
2023
Q2 | $425K | Hold |
7,562
| – | – | 0.01% | 360 |
|
|
2023
Q1 | $342K | Sell |
7,562
-1,872
| -20% | -$84.7K | 0.01% | 497 |
|
|
2022
Q4 | $383K | Sell |
9,434
-3,092
| -25% | -$126K | 0.01% | 637 |
|
|
2022
Q3 | $819K | Sell |
12,526
-545
| -4% | -$35.6K | 0.01% | 751 |
|
|
2022
Q2 | $794 | Buy |
13,071
+5,236
| +67% | +$318 | 0.01% | 1035 |
|
|
2022
Q1 | $492K | Buy |
+7,835
| New | +$492K | 0.01% | 915 |
|